Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Hungary

 

COVID widens fault line between outsourcing and private pay in Hungary

Hungary's private pay-focused operators should maintain double-digit growth in 2020 despite COVID-19 while those reliant on public outsourcing face an uncertain future, the chairman of the fourth-largest private acute care provider tells HBI. Affidea just lost a large outsourcing contract while a billionaire and venture capital funds have recently entered the market.

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.

Teleradiology’s elective volumes crash

Teleradiology providers across Europe have seen volumes crash for elective reads because of the shut down of non-essential work in public hospitals, while emergency reads have been less badly affected. But operators' low fixed costs should mean that profits will hold.

Five things we learnt at the Budapest Private Health Forum

This week HBI attended Portfolio's private healthcare forum in Budapest. We got an update on the country's ongoing insurance reform, the latest consolidation efforts and limp towards digitalisation. Here are our key takeaways: 

FREE BLOG Europe’s €18bn fragmented private imaging sector ripe for change

What has emerged during our research for HBI Intelligence's imaging report, now live on our site, is how fragmented the sector is compared to other services. It will be utterly revolutionised by regulatory and tariff changes, AI/teleradiology and changing service-supplier dynamics; it's just no one is sure exactly how.

Visualising the crisis in homecare staff

The ratio between nurses and personal carers and populations over 65 tells you a lot about a country's ability to provide adequate homecare. Here we track the number for eight OECD countries. Overall the ratio has dropped.

Bridgepoint “exploring” €2bn sale/IPO of Diaverum

As first reported by HBI, dialysis group Diaverum looks certain to be sold by Bridgepoint. Reuters now suggests that Diaverum is "exploring" and "testing the appetite" for a €2bn sale of the global dialysis group Diaverum. We go through potential buyers.

Interview: Dimitris Moulavasilis, CEO, Diaverum 

Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis. 

Find Us